Form 8-K COHERENT INC For: Jan 29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
�
FORM 8-K
�
CURRENT REPORT
�
Pursuant to Section�13 or 15(d) of the Securities Exchange Act of 1934
�
Date of Report (date of earliest event reported): January 29, 2015
�
COHERENT, INC.
(Exact name of registrant as specified in its charter)
�
Delaware | 001-33962 | 94-1622541 | ||
(State or other jurisdiction of incorporation) | (Commission File No.) | (IRS Employer Identification Number) | ||
�
5100 Patrick Henry Drive
Santa Clara, CA 95054
(Address of principal executive offices)
�
(408) 764-4000
(Registrants telephone number, including area code)
�
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
�
ITEM 2.02.���� | Results of Operations and Financial Condition |
�
On January 29, 2015, Coherent,�Inc. (the registrant or Coherent ) issued a press release regarding its financial results for the fiscal quarter ended December 27, 2014. A copy of the press release is furnished as Exhibit�99.1 to this report.
�
NON-GAAP FINANCIAL MEASURES: Coherent utilizes a number of different financial measures, both GAAP and non-GAAP, in analyzing and assessing the overall business performance, for making operating decisions and for forecasting and planning future periods. Coherent considers the use of non-GAAP financial measures helpful in assessing its current financial performance, ongoing operations and prospects for the future. Ongoing operations are the ongoing revenue and expenses of the business, excluding certain costs and expenses that Coherent does not anticipate to recur on a quarterly basis or which do not reflect ongoing operations. While Coherent uses non-GAAP financial measures as a tool to enhance its understanding of certain aspects of its financial performance, Coherent does not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial measures. Consistent with this approach, Coherent believes that disclosing non-GAAP financial measures to the readers of its financial statements provides such readers with useful supplemental data that, while not a substitute for GAAP financial measures, allows for greater transparency in the review of its financial and operational performance. In assessing the overall health of its business, Coherent excluded items in the following general categories described below:
�
Net income and net income per diluted share. �We have excluded certain recurring and non-recurring items in order to enhance investors understanding of our ongoing operations and to compare these results across multiple fiscal periods, particularly where a one-time event may have an impact in one fiscal quarter and not another.
�
Each of the non-GAAP financial measures described above, and used herein, should not be considered in isolation from, or as a substitute for, a measure of financial performance prepared in accordance with GAAP. Further, investors are cautioned that there are inherent limitations associated with the use of each of these non-GAAP financial measures as an analytical tool. In particular, these non-GAAP financial measures are not based on a comprehensive set of accounting rules�or principles and many of the adjustments to the GAAP financial measures reflect the exclusion of items that are recurring and will be reflected in Coherents financial results for the foreseeable future. In addition, other companies, including other companies in Coherents industry, may calculate non-GAAP financial measures differently than Coherent does, limiting their usefulness as a comparative tool.
ITEM 9.01.����Financial Statements and Exhibits
(d)����Exhibits
Exhibit No. | Description |
99.1 | Press release dated January 29, 2015 |
SIGNATURES
�
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
�
�
COHERENT, INC. | ||
Date: January 29, 2015 | ||
By: /s/ Bret M. DiMarco | ||
Bret M. DiMarco | ||
Executive Vice President and | ||
General Counsel | ||
�
Exhibit 99.1
PRESS RELEASE |
Editorial Contact: | For Release: | |
Helene Simonet | IMMEDIATE | |
(408) 764-4110 | January 29, 2015 | |
No. 1354 | ||
Coherent, Inc. Reports First Fiscal Quarter Results
SANTA CLARA, CA, January�29, 2015 -- Coherent, Inc. (NASDAQ, COHR), a world leader in providing photonics based solutions to the commercial and scientific research markets, today announced financial results for its first fiscal quarter ended December�27, 2014.
FINANCIAL HIGHLIGHTS
Three Months Ended | |||||||||||
Dec. 27, 2014 | Sept. 27, 2014 | Dec. 28, 2013 | |||||||||
GAAP Results | |||||||||||
(in millions except per share data) | |||||||||||
Bookings | $ | 162.5 | $ | 182.7 | $ | 201.5 | |||||
Net sales | $ | 200.6 | $ | 205.3 | $ | 193.6 | |||||
Net income | $ | 17.4 | $ | 19.1 | $ | 11.7 | |||||
Diluted EPS | $ | 0.69 | $ | 0.76 | $ | 0.47 | |||||
Non-GAAP Results | |||||||||||
(in millions except per share data) | |||||||||||
Net income | $ | 21.9 | $ | 24.2 | $ | 17.1 | |||||
Diluted EPS | $ | 0.87 | $ | 0.96 | $ | 0.68 | |||||
FIRST FISCAL QUARTER DETAILS
For the first fiscal quarter ended December�27, 2014, Coherent announced net sales of $200.6 million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $17.4 million, or $0.69 per diluted share. These results compare to net sales of $193.6 million and net income of $11.7 million, or $0.47 per diluted share, for the first quarter of fiscal 2014.
Non-GAAP net income for the first quarter of fiscal 2015 was $21.9 million, or $0.87 per diluted share. Non-GAAP net income for the first quarter of fiscal 2014 was $17.1 million, or $0.68 per diluted share. Reconciliations of GAAP to non-GAAP financial measures for the three months ended December 27, 2014, September 27, 2014 and December 28, 2013
Exhibit 99.1
appear in the financial statements portion of this release under the heading Reconciliation of GAAP to Non-GAAP net income."
�
Net sales for the fourth quarter of fiscal 2014 were $205.3 million and net income, on a GAAP basis, was $19.1 million, or $0.76 per diluted share. Non-GAAP net income for the fourth quarter of fiscal 2014 was $24.2 million, or $0.96 per diluted share.
Bookings received during the first fiscal quarter ended December�27, 2014 were $162.5 million. This result compares to bookings of $201.5 million in the same prior year period and $182.7 million in the immediately preceding quarter.
The book-to-bill ratio was 0.81, and ending backlog expected to ship in the next 12 months was $295.9 million at December�27, 2014, compared to a backlog of $328.3 million at September�27, 2014 and a backlog of $281.4 million at December�28, 2013.
We posted solid numbers in our first fiscal quarter with expected benefits arising from higher volume.� A better mix and lower warranty costs were positive contributors to gross profit percentage.� Orders reflected the timing of certain OEM bookings and are not indicative of either a market slowdown or changes in market share, said John Ambroseo, Coherents President and Chief Executive Officer. We were especially pleased to have delivered our first Triple Vyper" Linebeam 1500 system, which sets new standards for LTPS production.� The system is undergoing production qualification at the end users facility.� We plan to ship the second 1500 system by the end of the current fiscal quarter. The third and final unit from the original order is scheduled for the fourth fiscal quarter of 2015 per the customers request, Ambroseo said.
Coherent ended the quarter with cash, cash equivalents and short term investments of $323.0 million, an increase of $4.7 million from cash, cash equivalents and short term investments of $318.3 million at September�27, 2014.
On July 25, 2014, the Board of Directors authorized a buyback program whereby we are authorized to repurchase up to $25.0 million of our common stock from time to time through July 31, 2015. During the first quarter and through January 9, 2015, we repurchased and retired outstanding common stock for a total of $17.3 million and $7.7 million, respectively, under this plan.
On January 21, 2015, our board of directors authorized an additional stock repurchase program to repurchase up to $25 million of the Company's outstanding common stock through January 31, 2016.
CONFERENCE CALL REMINDER
The Company will host a conference call today to discuss its financial results at 1:30 P.M. Pacific (4:30 P.M. Eastern). A listen-only broadcast of the conference call can be accessed on the Company's website at http://www.coherent.com/Investors/. For those who are not able to listen to the live broadcast, the call will be archived for approximately three months on the company web site. A transcript of managements prepared remarks can be found at http://www.coherent.com/Investors/.
Exhibit 99.1
Summarized statement of operations information is as follows (unaudited, in thousands except per share data):
Three Months Ended | |||||||||||
Dec. 27, 2014 | Sept. 27, 2014 | Dec. 28, 2013 | |||||||||
Net Sales | $ | 200,615 | $ | 205,344 | $ | 193,556 | |||||
Cost of sales(A)(B)(C) | 118,296 | 124,426 | 116,010 | ||||||||
Gross profit | 82,319 | 80,918 | 77,546 | ||||||||
Operating expenses: | |||||||||||
Research & development(A)(B)� | 19,173 | 18,674 | 20,937 | ||||||||
Selling, general & administrative(A)(B)� | 38,141 | 37,617 | 39,891 | ||||||||
Intangibles amortization(C)� | 696 | 733 | 934 | ||||||||
Total operating expenses | 58,010 | 57,024 | 61,762 | ||||||||
Income from operations | 24,309 | 23,894 | 15,784 | ||||||||
Other income (expense), net(B) | (685 | ) | 1,756 | (220 | ) | ||||||
Income before income taxes | 23,624 | 25,650 | 15,564 | ||||||||
Provision for income taxes(D) | 6,194 | 6,553 | 3,861 | ||||||||
Net income | $ | 17,430 | $ | 19,097 | $ | 11,703 | |||||
Net income per share: | |||||||||||
Basic | $ | 0.70 | $ | 0.77 | $ | 0.48 | |||||
Diluted | $ | 0.69 | $ | 0.76 | $ | 0.47 | |||||
Shares used in computations: | � | ||||||||||
Basic | 24,936 | 24,880 | 24,542 | ||||||||
Diluted | 25,197 | 25,230 | 24,915 | ||||||||
(A) | Stock-related compensation expense included in operating results is summarized below (all footnote amounts are unaudited, in thousands, except per share data): |
Stock-related compensation expense | Three Months Ended | ||||||||
Dec. 27, 2014 | Sept. 27, 2014 | Dec. 28, 2013 | |||||||
Cost of sales | $ | 597 | $ | 596 | $ | 538 | |||
Research & development | 330 | 507 | 522 | ||||||
Selling, general & administrative | 3,463 | 3,587 | 3,808 | ||||||
Impact on income from operations | $ | 4,390 | $ | 4,690 | $ | 4,868 | |||
For the quarters ended December�27, 2014, September�27, 2014 and December�28, 2013, the impact on net income, net of tax was $3,960 ($0.16 per diluted share), $3,382 ($0.13 per diluted share) and $3,529 ($0.14 per diluted share), respectively.
Exhibit 99.1
(B) | Changes in deferred compensation plan liabilities are included in cost of sales and operating expenses while gains and losses on deferred compensation plan assets are included in other income (expense) net. Deferred compensation expense (benefit) included in operating results is summarized below: |
Deferred compensation expense | Three Months Ended | ||||||||
Dec. 27, 2014 | Sept. 27, 2014 | Dec. 28, 2013 | |||||||
Cost of sales | $ | 14 | $ | 24 | $ | 68 | |||
Research & development | 83 | 126 | 296 | ||||||
Selling, general & administrative | 428 | 651 | 1,823 | ||||||
Impact on income from operations | $ | 525 | $ | 801 | $ | 2,187 | |||
For the quarters ended December�27, 2014, September�27, 2014 and December�28, 2013, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was income of $449, $780 and $1,931, respectively.
(C) | For the quarters ended December�27, 2014, September�27, 2014 and December�28, 2013, the impact of amortization of intangibles expense was $2,180 ($1,607 net of tax ($0.06 per diluted share)), $2,312 ($1,713 net of tax ($0.07 per diluted share)) and $2,445 ($1,823 net of tax ($0.07 per diluted share)). |
(D) | The quarter ended December�27, 2014 included $1,118 ($0.04 per diluted share) non-recurring tax benefit from the renewal of the R&D tax credit for fiscal 2014. |
Summarized balance sheet information is as follows (unaudited, in thousands):
Dec. 27, 2014 | Sept. 27, 2014 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash, cash equivalents and short-term investments | $ | 322,951 | $ | 318,275 | |||
Accounts receivable, net | 130,461 | 137,324 | |||||
Inventories | 161,993 | 170,483 | |||||
Prepaid expenses and other assets | 57,786 | 54,973 | |||||
Total current assets | 673,191 | 681,055 | |||||
Property and equipment, net | 103,978 | 107,424 | |||||
Other assets | 200,838 | 210,896 | |||||
Total assets | $ | 978,007 | $ | 999,375 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 27,040 | $ | 32,784 | |||
Other current liabilities | 89,118 | 84,535 | |||||
Total current liabilities | 116,158 | 117,319 | |||||
Other long-term liabilities | 54,223 | 62,407 | |||||
Total stockholders equity | 807,626 | 819,649 | |||||
Total liabilities and stockholders equity | $ | 978,007 | $ | 999,375 | |||
Reconciliation of GAAP to Non-GAAP net income (unaudited, in thousands, net of tax):
Exhibit 99.1
Three Months Ended | |||||||||
Dec. 27, 2014 | Sept. 27, 2014 | Dec. 28, 2013 | |||||||
GAAP net income | $ | 17,430 | $ | 19,097 | $ | 11,703 | |||
Stock-related compensation expense | 3,960 | 3,382 | 3,529 | ||||||
Intangibles amortization | 1,607 | 1,713 | 1,823 | ||||||
Non-recurring tax benefit | (1,118 | ) | |||||||
Non-GAAP net income | $ | 21,879 | $ | 24,192 | $ | 17,055 | |||
Non-GAAP net income per diluted share | $ | 0.87 | $ | 0.96 | $ | 0.68 | |||
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements, as defined under the Federal securities laws. These forward-looking statements include the statements in this press release that relate to the timing of shipment for the Companys products and the timing of production qualification of our products. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to differ materially and adversely from those expressed in any forward-looking�statement.� Factors that could cause actual results to differ materially include risks and uncertainties, including, but not limited to, risks associated with any general market recovery, the timing and success of production qualification of our Linebeam 1500 system,�our and our customers exposure to risks associated with worldwide economic conditions, the mix and pricing of our products, our ability to control expenses, the ability of our customers to forecast their own end markets, our ability to accurately forecast future periods, customer acceptance and adoption of our new product offerings, continued timely availability of products and materials from our suppliers, our ability to timely ship our products and our customers ability to accept such shipments, our ability to have our customers qualify our product offerings, and other risks identified in the Companys SEC filings.� Readers are encouraged to refer to the risk disclosures and critical accounting policies and estimates described in the Companys reports on Forms 10-K, 10-Q and 8-K, as applicable and as filed from time-to-time by the Company.� Actual results, events and performance may differ materially from those presented herein.� Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.� The Company undertakes no obligation to update these forward-looking statements as a result of events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Standard & Poors SmallCap 600 Index and the Russell 2000. Please direct any questions to Helene Simonet, Chief Financial Officer at 408-764-4110. For more information about Coherent, visit the Company's Web site at http://www.coherent.com/ for product and financial updates.
5100 Patrick Henry Dr. . P. O. Box 54980, Santa Clara, California 950560980 . Telephone (408) 764-4000